Weight-Loss drug investigated as potential kidney protector
NCT ID NCT05536804
Summary
This study is investigating whether the medication tirzepatide, which is approved for weight loss and diabetes, can improve kidney health in people who are overweight or obese and have chronic kidney disease. Researchers will use special MRI scans to see if the drug increases oxygen levels in the kidneys and reduces kidney fat. The goal is to see if this medication can help control kidney disease progression in this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus Universitetshospital, Skejby
Aarhus, 8200, Denmark
-
American Health Network of Indiana, LLC - Avon
Avon, Indiana, 46123, United States
-
American Health Network of Indiana, LLC - Greenfield
Greenfield, Indiana, 46140, United States
-
American Health Network of Indiana, LLC - Muncie
Muncie, Indiana, 47304, United States
-
Amsterdam UMC, locatie VUmc
Amsterdam, 1081 HV, Netherlands
-
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, 48098, United States
-
Caimed Investigacion En Salud S.A. de C.V.
Mexico City, 06760, Mexico
-
Centre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire -T
Sherbrooke, J1H 5N4, Canada
-
Centro de Investigación y Gastroenterología
Cuauhtémoc, 06700, Mexico
-
Fadia El Boreky Medicine
Waterloo, N2J 1C4, Canada
-
Grupo Medico Camino Sc
Mexico City, 03310, Mexico
-
Health Pharma Professional Research S.A. de C.V:
Mexico City, 03100, Mexico
-
Indiana University Health University Hospital
Indianapolis, Indiana, 46202, United States
-
Instituto Nacional de Cardiologia Ignacio Chavez
México, 14080, Mexico
-
Investigación Nefrológica
Cuernavaca, 62448, Mexico
-
Kidney Associates of Colorado
Denver, Colorado, 80210, United States
-
Klinik Hietzing
Vienna, 1130, Austria
-
Klinik Landstraße
Vienna, 1030, Austria
-
LMC Clinical Research Inc. (Barrie)
Barrie, L4N 7L3, Canada
-
LMC Clinical Research Inc. (Thornhill)
Concord, L4K 4M2, Canada
-
Providence Medical Research Center - Spokane
Spokane, Washington, 99204, United States
-
Toronto General Hospital
Toronto, M5G 2C4, Canada
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
-
University of Washington Medical Center - Montlake
Seattle, Washington, 98195, United States
-
Valley Clinical Trials, Inc.
Northridge, California, 91325, United States
-
Zentrum für klinische Studien Dr Hanusch Gmbh
Vienna, 1060, Austria
-
Ziekenhuisgroep Twente, locatie Almelo
Almelo, 7609 PP, Netherlands
Conditions
Explore the condition pages connected to this study.